These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30836152)
21. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Kumar D; Sailaja Chirravuri SV; Shastri NR Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106 [TBL] [Abstract][Full Text] [Related]
22. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of mesoporous silica particles as drug carriers in hydrogels. Lunter DJ Pharm Dev Technol; 2018 Oct; 23(8):826-831. PubMed ID: 28826298 [TBL] [Abstract][Full Text] [Related]
24. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl. Varshosaz J; Dayani L; Chegini SP; Minaiyan M IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744 [TBL] [Abstract][Full Text] [Related]
25. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479 [TBL] [Abstract][Full Text] [Related]
26. Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity. Wei Y; Zhang J; Zhou Y; Bei W; Li Y; Yuan Q; Liang H Carbohydr Polym; 2017 Mar; 159():152-160. PubMed ID: 28038744 [TBL] [Abstract][Full Text] [Related]
27. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin. Li Y; Rantanen J; Yang M; Bohr A Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059 [TBL] [Abstract][Full Text] [Related]
28. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. Vadia N; Rajput S Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974 [TBL] [Abstract][Full Text] [Related]
29. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
30. Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics. Šoltys M; Zůza D; Boleslavská T; Machač Akhlasová S; Balouch M; Kovačík P; Beránek J; Škalko-Basnet N; Flaten GE; Štěpánek F Int J Pharm; 2021 Sep; 607():120982. PubMed ID: 34371148 [TBL] [Abstract][Full Text] [Related]
31. Mesoporous silica formulation strategies for drug dissolution enhancement: a review. McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory mechanisms of glabridin on tyrosinase. Chen J; Yu X; Huang Y Spectrochim Acta A Mol Biomol Spectrosc; 2016 Nov; 168():111-117. PubMed ID: 27288962 [TBL] [Abstract][Full Text] [Related]
33. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of Pore-Size-Tunable Mesoporous Silica Nanoparticles by Simultaneous Sol-Gel and Radical Polymerization to Enhance Silibinin Dissolution. Shafiee M; Abolmaali S; Abedanzadeh M; Abedi M; Tamaddon A Iran J Med Sci; 2021 Nov; 46(6):475-486. PubMed ID: 34840388 [TBL] [Abstract][Full Text] [Related]
35. Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations. Gumaste SG; Serajuddin ATM Eur J Pharm Sci; 2017 Dec; 110():134-147. PubMed ID: 28506870 [TBL] [Abstract][Full Text] [Related]
36. Inclusion of water insoluble drugs in amorphous silica nanoparticles. Patil A; Lafarga AA; Chebrot M; Lamprou DA; Urquhart A; Douroumis D J Biomed Nanotechnol; 2012 Aug; 8(4):550-7. PubMed ID: 22852464 [TBL] [Abstract][Full Text] [Related]
37. Identification of glabridin as a bioactive compound in licorice (Glycyrrhiza glabra L.) extract that activates human peroxisome proliferator-activated receptor gamma (PPARγ). Rebhun JF; Glynn KM; Missler SR Fitoterapia; 2015 Oct; 106():55-61. PubMed ID: 26297329 [TBL] [Abstract][Full Text] [Related]
38. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles. Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956 [TBL] [Abstract][Full Text] [Related]
39. Role of Fine Silica as Amorphous Solid Dispersion Carriers for Enhancing Drug Load and Preventing Recrystallization- A Comprehensive Review. Trivedi R; Chatterjee B; Kalave S; Pandya M Curr Drug Deliv; 2023; 20(6):694-707. PubMed ID: 35899950 [TBL] [Abstract][Full Text] [Related]